Hoyoung Huh's Net Worth

$8.43 Million

Estimate Recalculated Jul 12, 2024 05:47PM EST

Who is Hoyoung Huh?

Hoyoung Huh has an estimated net worth of $8.43 Million. This is based on reported shares across multiple companies, which include FACET BIOTECH CORP, PLIANT THERAPEUTICS, INC., GERON CORP, NEKTAR THERAPEUTICS, Eidos Therapeutics, Inc., AntriaBio, Inc., CytomX Therapeutics, Inc., and Peak Bio, Inc..

SEC CIK

Hoyoung Huh's CIK is 0001401267

Past Insider Trading and Trends

2023 was Hoyoung Huh's most active year for acquiring shares with 28 total transactions. Hoyoung Huh's most active month to acquire stocks was the month of July. 2023 was Hoyoung Huh's most active year for disposing of shares, totalling 3 transactions. Hoyoung Huh's most active month to dispose stocks was the month of March. 2007 saw Hoyoung Huh paying a total of $1,084,000.00 for 350,000 shares, this is the most they've acquired in one year. In 2010 Hoyoung Huh cashed out on 25,000 shares for a total of $675,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

FACET BIOTECH CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.33K
$27.00
-$224,991.00
0
Apr 21
Form 4
∞
8.33K
—
—
8.33K
Sep 5
Form 3
—
0
—
—
0
No matching records found

PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $16

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 29
Form 4
+140.20%
139.86K
—
—
239.62K
Jun 5
Form 3
—
0
—
—
0
No matching records found

GERON CORP (GERN) Snapshot price: $1.905

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 15
Form 4
+7.50%
10.76K
—
—
154.3K
Dec 29
Form 4
+6.60%
8.89K
—
—
143.54K
Sep 29
Form 4
+5.48%
7K
—
—
134.65K
Jun 30
Form 4
—
0
—
—
0
May 9
Form 4
+7.17%
8.54K
—
—
127.65K
Mar 31
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 18
Form 4
-7.74%
-10.00K
—
—
119.12K
Jun 30
Form 4
—
0
—
—
0
May 20
Form 4
+7.73%
9.27K
—
—
129.12K
Mar 31
Form 4
+3.53%
4.09K
—
—
119.85K
Dec 31
Form 4
+5.26%
5.78K
—
—
115.76K
Sep 30
Form 4
-29.04%
-45.00K
—
—
109.98K
Jul 9
Form 4
+8.74%
12.45K
—
—
154.98K
Jun 28
Form 4
—
0
—
—
0
May 22
Form 4
-6.56%
-10.00K
—
—
142.53K
Dec 31
Form 4
+16.21%
21.28K
—
—
152.53K
May 17
Form 4
+59.09%
48.75K
—
—
131.25K
May 20
Form 4
+83.33%
37.5K
—
—
82.5K
Mar 9
Form 4
∞
45K
—
—
45K
Jul 9
Form 3
—
0
—
—
0
No matching records found

NEKTAR THERAPEUTICS (NKTR) Snapshot price: $0.7

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 2
Form 4
—
0
—
—
0
Mar 20
Form 4/A
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Dec 21
Form 4
—
0
—
—
0
Jun 6
Form 3
—
0
—
—
0
No matching records found

Eidos Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 22
Form 3
—
0
—
—
0
No matching records found